Joyvié Health Raises $1.04M to Redesign Continence Care

Jan de Vries · 2026-06-05

A UK-based startup called Joyvié Health just closed its pre-Seed funding round, pulling in $1.04 million for a product that could change how we think about continence care. The money comes from an Innovate UK grant, along with investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and a few individual angel investors. Their focus? A new kind of continence underwear designed from the ground up to cut down on stool-to-skin contact, keep skin healthy, and make life easier for caregivers. "Products designed for care should never cause harm. That's not a vision statement. It's the reason this company exists," says Zoe Robson, Founder and CEO of Joyvié Health. ### A Personal Story That Sparked a Mission Joyvié Health wasn't born in a boardroom. It came from a painful, personal experience. Zoe Robson founded the company after her father, Fred, passed away in 2025. Fred was 77, fit, and sharp-minded when he got a late-stage pancreatic cancer diagnosis on Christmas Eve 2024. Eleven weeks later, he was gone. During those weeks, Fred lost bowel control and had to wear a nappy. The problem? When feces stays trapped against skin, it breaks it down. Moisture, pathogens, and pH imbalances cause damage that never fully heals. Fred's skin broke down. His dignity slipped away, change by change. And then there was Ruth, his wife and primary caregiver. She carried a burden that was invisible to the outside world and impossibly hard to bear. "My parents didn't deserve that," says Zoe. "They were both at their most vulnerable, and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mom. It wasn't from lack of care. It's a design failure."  ### A Better Design for a Massive Problem Here's the core issue: fecal incontinence affects an estimated 656 million people worldwide. Yet the most common non-invasive solution has barely changed in decades. We're still using nappies and pads. Joyvié's approach is different. Instead of trapping stool against the skin, their product contains it in a disposable pouch right after excretion. Early testing shows about 90% less stool-to-skin contact and changes that are roughly 70% faster. That's a huge leap. Less contact means less skin breakdown. Faster changes mean less burden on caregivers. And preserving dignity? That's priceless.  ### The Bigger Picture: HealthTech Funding in 2026 Joyvié's pre-Seed round is part of a much larger wave. Across the UK and Europe, HealthTech companies are pulling in serious cash. We're talking over $182 million in related funding just in 2026. Here's a quick look at some of the other players: - **Semble** raised $36.2 million to scale its healthcare management platform for outpatient providers - **Evaro** secured $21.9 million to expand NHS-licensed embedded health services - **Recare** in Berlin raised up to $38.6 million for its AI platform for hospitals and care providers - **Tucuvi** raised $17.7 million to scale voice-AI nursing follow-up automation - **ShanX Medtech** secured $25 million to advance antimicrobial-resistance diagnostics These aren't random bets. They're all aimed at improving care delivery, clinical workflows, elderly care, medical devices, and women's health. "At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people's lives," says Gail Armstrong of Lavender Ventures. "We believe the market is ripe for innovation, and Joyvié's approach has the potential to deliver significant benefits not only for individuals but also for carers, healthcare systems, and the environment." ### What This Means for the Future Joyvié Health is on a mission to end the silent humiliation of fecal incontinence. It's a condition that's often hidden, rarely discussed, and massively underserved. But with this funding and a product that actually works differently, they're giving hope to millions. For Zoe Robson, it's personal. For the rest of us, it's a reminder that sometimes the best innovations come from the hardest moments. And if Joyvié can deliver on its promise, it won't just be a win for the company. It'll be a win for everyone who's ever felt forgotten by the system.